Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-101 Monotherapy and AB-101 With Rituximab in Patients with Relapsed/Refractory Non?Hodgkin Lymphoma of B-Cell Origin

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT04673617
Protocol Number
NSH1303
Phase
I/II
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Non-Hodgkin's Lymphoma
Sponsor Protocol
AB-101-01
Principal Investigator
Lawrence Morris
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us